Skip to main content

Xanax Schmanax

As geriatricians and providers who work with older adults, many of whom are frail, we carry amongst our mantras the avoidance of benzodiazepines (xanax, halcion, ativan, valium to name a handful). Since the inception of the Beers Criteria on Potentially Inappropriate Medications for older adults, benzodiazepines have maintained their steady presence. (see post: http://www.geripal.org/2012/03/beers-criteria-contest-submit-craziest.html) Sadly, I see in my geriatrics practice that benzodiazepines also remain a common prescription for older adults in the community to treat everything from anxiety to insomnia, muscle aches and pain to fear of flying. The patient alluded to in the previous geripal post above who was on valium, halcion, ativan, and doxepin was only one of the MANY patients I encounter in my primary care and consult practice. While her combination of prescriptions was horrifying, I often feel equally depressed and frustrated when I see new patients who come to me with just one benzodiazepine. It is not uncommon that I have new patients who have been prescribed two: valium and restoril, ativan and clonazepam, ativan and restoril etc. Why does this upset me so? Just this week I met two new patients who were both on benzodiazepines. One was a 90 year old woman who was prescribed xanax a few years ago to help her with longstanding anxiety which has worsened as she has aged. She herself stated that her desire was to "not become addicted" to xanax (one of the RARE patients I meet on benzodiazepines who actually WANTS to come off). She has had a fall significant enough to cause a subdural hematoma. The second patient I saw was prescribed two benzodiazepines--because she moved here from Europe I had to look up the medication names she had been taking "for years" and, unfortunately, she has been on quite significant doses of both. She presented to me with what I see classically in long-standing benzodiazepine users--a tremendous relief when she takes the medication for her sleep but then a subsequent "wear off" effect where her anxiety rises through the day until she's in desperation by bedtime. Most of the new patients I see on benzodiazepines absolutely LOVE their benzos. The majority of them also complain to me of unsteadiness on their feet, history of falls, depression, trouble with memory. Benzos may not be directly correlated with all of these complaints, or even with my 90yo woman's prior fall above. But they sure raise my concern. While some of these patients have had a trial of SSRIs--and fewer a trial of therapy, sleep training, meditation or other treatment--many of these patients coming to me have not had a trial of ANY OTHER treatment for their anxiety, insomnia, etc. My concern about how widely benzodiazepines are doled out to patients in their 70s, 80s, 90s is that this may seem like a quick fix for a patient's anxiety, insomnia, or whatever is ailing them. (And I fully recognize that some patients may directly approach their primary care provider with a request for xanax, valium or ativan.) But the downstream sequelae is that these patients (almost always) become incredibly attached to their benzos and inevitably are at risk, as they age, of significant adverse effects. And almost all of them are reluctant to come off the medication--even if their anxiety or insomnia are not as well-managed as they themselves would like. Indeed, a number of patients on longstanding benzos develop WORSENING of anxiety, sleep and depression over time. I shudder when I see a new patient in my practice who is frail, wobbly, and cognitively impaired who complains to me not only of anxiety or insomnia but that their walking is unsteady, they keep falling, or they just can't think the way they used to. Most of the time, these patients also have the usual combination of chronic illness which need to be addressed--hypertension, diabetes, heart failure, COPD etc. The quick fix medication becomes the locus of what often ends up being a months-long (sometimes years-long) process of educating my patient (or their family/caregiver) about how we can better treat their anxiety and insomnia, and carefully taper them down. I am not always successful (yet) with some patients. But I (and many families and patients) do often find success at the end of a LONG road to taper benzodiazepines. What is unfortunate is that the time and effort to slowly, carefully and always reassuringly taper someone down off a medication they have long-perceived to be a lifeline to calm and peace, is arduous and often takes up significant time in clinic sessions such that addressing their chronic conditions, or even acute illnesses, have to constantly be re-triaged. I do not have a 100% avoidance policy against benzodiazedines. There are a small number of indications for which benzodiazepines can be very appropriate. And, certainly, within the more palliative-hospice goal-directed care I provide for patients approaching death, benzodiazepines can be incredibly helpful. But how do we educate our patients and colleagues in health care that benzodiazepines should NEVER be the firstline prescription handed to an older adult for anxiety or insomnia. by: Helen Kao

Comments

Helen Chen, MD said…
Helen, I've definitely seen this disturbing benzo phenomenon too. Unfortunately, there are many competing pressures/problems that may not be entirely soluble with just education. There are many people who believe in "better living through pharmaceuticals" prescribed or otherwise. I would also argue that many physicians want to say "yes" to patient requests--we are after all in a helping profession--and I wonder if the bonus-related effects of Press-Ganey, HCAHPS scores, and other patient satisfaction incentive programs also potentiate this problem.

That being said, it has always been my contention that 21st century medicine addresses the question "can we?" while 21st century geriatricians/geriatrics focused healthcare professionals attempt to reframe the question as "should we?" Saying no in a positive way takes courage, stamina, and in some cases, institutional support.

Helen C.
Amen and right on to both Helens. As a Geriatric Care Manager specializing in the Dementias, when I go into a home, far,far too often I see one or more bottles of benzos for the person with dementia. What's worse is it is seen as the answer by the family, rather than having to put more effort into caregiving that engages the person, not sedates them.
Anonymous said…
This is very interesting. I'm in a situation where an elderly in-law is having very serious anxiety as well as many other geriatric issues, including unsteadiness. We're a long ways away from her and there really are no more local family caregivers, so we're very dependent on the professional medical support she can receive through various assistance programs. She's on xanax at the moment. I'm reluctant therefore to question their judgment and yet I'm also wary personally of psychiatric medicines and the propensity to overmedicate. I just don't know how plausible the alternative you suggest here is in our situation or many others--e.g., if the alternative involves extensive clinic sessions, it's just not going to happen for all sorts of reasons. She was experiencing fragility and acute anxiety before being medicated as well, so it's terrible hard to even guess what part might involve pharmaceutical effects and what else is involved.
Anonymous said…
My dad was in the hospital for a spell and doing well. He was about to come home and evidently awoke early one morning and demanded to go home. The nurses called his doctor and he prescribed Xanax for him. When I arrived a few hours later, my dad was like a zombie.......could not talk correctly, or control his arms or legs. He went downhill from there....and never recovered. I think they sent him home with pills for "anxiety, so he was probably taking a bit each day......his body just shut down slowly. On his death certificate they wrote "congestive heart failure", yet his legs were not swollen at all and his heart and breathing seemed fine. My dad realized they had done something to him, because a day after the first time they gave him the Xanax he rallied enough to tell me to "Sue the #@$%** if I don't come out of this"......and he didn't. When you see an elderly patient tied to a hospital bed, moaning and trying to talk, but all they can do is sound like a wailing animal, you can be pretty sure they are not crazy, but have been given an overdoes of seditives to shut them up and render them powerless.

Popular posts from this blog

Lost in Translation: Google’s Translation of Palliative Care to ‘Do-Nothing Care’

by: Cynthia X. Pan, MD, FACP, AGSF (@Cxpan5X)

My colleagues often ask me: “Why are Chinese patients so resistant to hospice and palliative care?” “Why are they so unrealistic?” “Don’t they understand that death is part of life?” “Is it true that with Chinese patients you cannot discuss advance directives?”

As a Chinese speaking geriatrician and palliative care physician practicing in Flushing, NY, I have cared for countless Chinese patients with serious illnesses or at end of life.  Invariably, when Chinese patients or families see me, they ask me if I speak Chinese. When I reply “I do” in Mandarin, the relief and instant trust I see on their faces make my day meaningful and worthwhile.

At my hospital, the patient population is about 30% Asian, with the majority of these being Chinese. Most of these patients require language interpretation.  It becomes an interesting challenge and opportunity, as we often need to discuss advance directives, goals of care, and end of life care options…

Delirium: A podcast with Sharon Inouye

In this week's GeriPal podcast we discuss delirium, with a focus on prevention. We are joined by internationally acclaimed delirium researcher Sharon Inouye, MD, MPH. Dr Inouye is Professor of Medicine at Harvard Medical School and Director of the Aging Brain Center in the Institute for Aging Research at Hebrew SeniorLife.

Dr. Inouye's research focuses on delirium and functional decline in hospitalized older patients, resulting in more than 200 peer-reviewed original articles to date. She has developed and validated a widely used tool to identify delirium called the Confusion Assessment Method (CAM), and she founded the Hospital Elder Life Program (HELP) to prevent delirium in hospitalized patients.

We are also joined by guest host Lindsey Haddock, MD, a geriatrics fellow at UCSF who asks a great question about how to implement a HELP program, or aspects of the program, in a hospital with limited resources.  


You can also find us on Youtube!


Listen to GeriPal Podcasts on:
iTunes…

Are Palliative Care Providers Better Prognosticators? A Podcast with Bob Gramling

Estimating prognosis is hard and clinicians get very little training on how to do it.  Maybe that is one of the reasons that clinicians are more likely to be optimistic and tend to overestimate patient survival by a factor of between 3 and 5.  The question is, aren't we better as palliative care clinicians than others in estimating prognosis?  This is part of our training and we do it daily.   We got to be better, right? 

Well, on todays podcast we have Bob Gramling from the Holly and Bob Miller Chair of Palliative Medicine at the University of Vermont to talk about his paper in Journal of Pain and Symptom Management (JPSM) titled “Palliative Care Clinician Overestimation of Survival in Advanced Cancer: Disparities and Association with End of Life Care”.

Big findings from this JPSM paper include that we, like all other clinicians, are an optimistic bunch and that it actually does impact outcomes.   In particular, the people whose survival was overestimated by a palliative care c…